Impaired miR-146a expression links subclinical inflammation and insulin resistance in Type 2 diabetes.
Type 2 diabetes patients exhibit subclinical inflammation but the regulatory mechanisms are poorly understood. We sought to evaluate the role of miR-146a expression along with its downstream proinflammatory signals in relation to glycemic control and insulin resistance. Study subjects (n = 20 each) comprised of clinically well characterized Type 2 diabetes patients and control non-diabetic subjects. miRNA and mRNA expression levels were probed in peripheral blood mononuclear cells (PBMC) by Real-time RT-PCR and plasma levels of TNFα and IL-6 were measured by ELISA. The miR-146a expression levels were significantly decreased in PBMCs from patients with Type 2 diabetes compared to control subjects. Among the target genes of miR-146a, TRAF-6 mRNA expression was significantly increased in patients with Type 2 diabetes while there was no significant difference in the mRNA levels of IRAK1 in the study groups. In contrast, there were significantly increased levels of NFκB expression in patients with Type 2 diabetes. There was an increased trend in the levels of TNFα and IL-6 mRNA in patients with type 2 diabetes. While SOCS-3 mRNA levels increased, plasma TNFα and IL-6 levels were also significantly higher in patients with type 2 diabetes. miR-146a expression was negatively correlated to glycated hemoglobin, insulin resistance, TRAF6, and NFκB mRNA levels and circulatory levels of TNFα and IL-6. Reduced miR-146a levels are associated with insulin resistance, poor glycemic control, and several proinflammatory cytokine genes and circulatory levels of TNFα and IL-6 in Asian Indian Type 2 diabetic patients.
Department of Cell and Molecular Biology, Madras Diabetes Research Foundation, Gopalapuram, Chennai 600086, India. balusignal@gmail.com
M
M
Balasubramanyam
S
S
Aravind
K
K
Gokulakrishnan
P
P
Prabu
C
C
Sathishkumar
H
H
Ranjani
V
V
Mohan
D000328:Adult; D001786:Blood Glucose / Q000032:analysis; D016022:Case-Control Studies; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000235:genetics* / Q000473:pathology; D004797:Enzyme-Linked Immunosorbent Assay; D006801:Humans; D007249:Inflammation / Q000150:complications / Q000235:genetics* / Q000473:pathology; D007333:Insulin Resistance; D015850:Interleukin-6 / Q000097:blood; D035683:MicroRNAs / Q000235:genetics*; D008875:Middle Aged; D020133:Reverse Transcriptase Polymerase Chain Reaction; D014409:Tumor Necrosis Factor-alpha / Q000097:blood
D001786:Blood Glucose; D015850:Interleukin-6; C542542:MIRN146 microRNA, human; D035683:MicroRNAs; D014409:Tumor Necrosis Factor-alpha
Diabetes. 2005 Oct;54(10):2939-45
16186396
Acta Physiol (Oxf). 2010 Jul 1;199(3):339-46
20136795
Proc Natl Acad Sci U S A. 2004 Mar 2;101(9):2999-3004
14973191
Arthritis Rheum. 2009 Apr;60(4):1065-75
19333922
Diabetes. 2009 Nov;58(11):2555-64
19720801
Arthritis Rheum. 2008 May;58(5):1284-92
18438844
J Assoc Physicians India. 2003 Sep;51:863-70
14710970
Diabetes Res Clin Pract. 2001 May;52(2):119-23
11311966
Mol Endocrinol. 2006 Jul;20(7):1587-96
16543409
J Am Soc Nephrol. 2010 May;21(5):763-72
20185635
JAMA. 2009 Sep 16;302(11):1186-94
19755697
Cell. 2004 Jan 23;116(2):281-97
14744438
Diabetologia. 1998 Oct;41(10):1241-8
9794114
Nat Med. 2005 Feb;11(2):183-90
15685173
Diabetologia. 2008 Oct;51(10):1873-82
18648765
Mech Ageing Dev. 2003 Apr;124(4):495-502
12714258
Clin Exp Dermatol. 2008 May;33(3):312-5
18419608
Horm Metab Res. 2007 Oct;39(10):758-63
17952840
Trends Endocrinol Metab. 2009 Nov;20(9):452-9
19800254
Am J Physiol. 1993 Aug;265(2 Pt 1):C321-7
8396324
J Biol Chem. 2004 Dec 3;279(49):51697-703
15465816
Mol Cell Biochem. 2009 Apr;324(1-2):173-81
19118408
Metabolism. 2006 Sep;55(9):1232-8
16919544
Diabetes Care. 1998 Aug;21(8):1310-6
9702439
Pharmacol Rep. 2009 Jul-Aug;61(4):595-603
19815941
Proc Natl Acad Sci U S A. 2008 May 20;105(20):7269-74
18474871
J Clin Invest. 1996 Feb 15;97(4):1111-6
8613535
Mol Cell Biol. 2004 Jun;24(12):5434-46
15169905
Mol Cell Biol. 2000 Sep;20(17):6342-53
10938111
Arthritis Res Ther. 2008;10(4):R101
18759964
Diabetologia. 2004 Nov;47(11):1998-2011
15578154
Am J Physiol Endocrinol Metab. 2001 May;280(5):E745-51
11287357
RNA. 2009 Sep;15(9):1640-51
19617315
RNA. 2008 Mar;14(3):417-24
18174313
Diabetes Care. 2008 Dec;31(12):2338-43
18796620
Science. 2001 Aug 31;293(5535):1673-7
11533494
J Clin Invest. 2006 Jul;116(7):1793-801
16823477
Clin Biochem. 2008 May;41(7-8):480-5
18328265
Int J Biochem Cell Biol. 2007;39(9):1673-84
17540609
Exp Mol Pathol. 2007 Jun;82(3):280-3
17382928
Diabet Med. 1998 Jul;15(7):539-53
9686693
Proc Natl Acad Sci U S A. 2006 Aug 15;103(33):12481-6
16885212
J Immunol. 2009 Aug 1;183(3):2150-8
19596990
Trends Immunol. 2008 Jul;29(7):343-51
18515182